Records containing: Venous Thromboembolism
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-05-08Controlled, Double-Blind, Randomised, Dose-Ranging Study on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement- ODIXa-HIP2 Study BAY 59-7939
-
CLINICAL_TRIALS study record update · 2008-12-18Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients
-
CLINICAL_TRIALS study record update · 2008-12-10A Multicenter, Randomized, Double-Blind, Double Dummy, Parallel Group, Dose Ranging Study of Subcutaneous SR123781A With an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
-
CLINICAL_TRIALS study record update · 2008-06-13ClinicalTrials.gov study NCT00361647
-
CLINICAL_TRIALS study record update · 2008-06-03Phase IV, Randomized, Open-Label Trial Comparing Long-Term Subcutaneous Low-Molecular Weight Heparin With Oral Anticoagulant Therapy in the Treatment of Deep Venous Thrombosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2007-12-11A Non-Randomized Prospective Study of IVC Filter Retrieval
-
CLINICAL_TRIALS study record update · 2007-07-16Assessment of Sleep Apnea Syndrome as a Risk Factor for Venous Thromboembolism
-
CLINICAL_TRIALS study record update · 2007-04-27A Trial of Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients (PRODIGE)
-
CLINICAL_TRIALS study record update · 2007-04-11Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
-
CLINICAL_TRIALS study record update · 2007-02-21Thromboprophylaxis in Critically Ill Patients: a Prospective, Randomized Study Comparing Anti-Xa Activities Following Subcutaneous Administration of 5000 IU and 7500 IU Dalteparin